Publication | Closed Access
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab
173
Citations
39
References
2006
Year
ImmunologyDifferent ModeAntibody ScreeningAutoimmunityCd22-targeting RecombinantAntibody EngineeringImmune Checkpoint InhibitorImmunotherapyMedicineRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1